bioRxivImmunology
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain
G. Cerutti, Y. Guo, P. Wang, M. S. Nair, Y. Huang, J. Yu, L. Liu, P. S. Katsamba, F. Bahna, E. R. Reddem, P. D. Kwong, D. D. Ho, Z. Sheng, L. Shapiro
Abstract
Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 [A] resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hydrophobic pocket between the two sheets of the NTD {beta}-sandwich. Interestingly, this pocket has been previously identified as the binding site for hydrophobic molecules including heme metabolites, but we observe their presence to not substantially impede 5-7 recognition. Mirroring its distinctive binding, antibody 5-7 retains a distinctive neutralization potency with variants of concern (VOC). Overall, we reveal a hydrophobic pocket in NTD proposed for immune evasion can actually be used by the immune system for recognition. HighlightsO_LICryo-EM structure of neutralizing antibody 5-7 in complex with SARS CoV-2 spike C_LIO_LI5-7 recognizes NTD outside of the previously identified antigenic supersite C_LIO_LI5-7 binds to a site known to accommodate numerous hydrophobic ligands C_LIO_LIStructural basis of 5-7 neutralization tolerance to some variants of concern C_LI
- organism: virus
- assay: structural biology
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite
G. Cerutti, Y. Guo, … L. Shapiro·bioRxiv·Jan 10, 2021
- N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
M. McCallum, A. De Marco, … D. Veesler·bioRxiv·Jan 14, 2021
- Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins
Z. Wang, F. Muecksch, … M. C. Nussenzweig·bioRxiv·Feb 1, 2022
- Structure of a germline-like human antibody defines a neutralizing epitope on the SARS-CoV-2 spike NTD
C. G. Altomare, D. C. Adelsberg, … G. Bajic·bioRxiv·Jul 8, 2021
- Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain
Xiao Niu, Zhiqiang Li, … Yunlong Cao·Emerging Microbes & InfectionsPeer-reviewed·Oct 3, 2024
- Defining the Antigenic Topology and Prospective Binding Breadth of Vaccination-induced SARS-CoV-2 Neutralizing Antibodies
Deepika Jaiswal, Clara G. Altomare, … Goran Bajic·bioRxiv·Mar 4, 2026